SUPERBODYMD Trademark

Trademark Overview


On Tuesday, October 31, 2023, a trademark application was filed for SUPERBODYMD with the United States Patent and Trademark Office. The USPTO has given the SUPERBODYMD trademark a serial number of 98247628. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, June 17, 2024. This trademark is owned by Vossi Bop LLC. The SUPERBODYMD trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Health care services, namely, telehealth for weight loss medication
superbodymd

General Information


Serial Number98247628
Word MarkSUPERBODYMD
Filing DateTuesday, October 31, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSUPER BODY MD
Goods and ServicesHealth care services, namely, telehealth for weight loss medication

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVossi Bop LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92101

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023NEW APPLICATION ENTERED
Wednesday, January 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 11, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 13, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 13, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, June 17, 2024NON-FINAL ACTION WRITTEN
Monday, June 17, 2024NON-FINAL ACTION E-MAILED